Yu‐Tzu Chang

Also affiliated with National Cheng Kung University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells”.

Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells

International Journal of Molecular Sciences(2023)10.3390/ijms241813972

N/A

0DataRank · unranked

17 citations

Yen-Ching Li, Megumi Murakami, Sung-Han Hsiao, Yun-Chieh Lee, Yang-Hui Huang +5 more

Imperatorin Restores Chemosensitivity of Multidrug-Resistant Cancer Cells by Antagonizing ABCG2-Mediated Drug Transport

Pharmaceuticals(2023)10.3390/ph16111595

N/A

0DataRank · unranked

3 citations

Megumi Murakami, Yen-Ching Li, Yang-Hui Huang, Yu‐Tzu Chang, Tai‐Ho Hung +3 more

Glucagon-like Peptide‐1 Agonists Reduce Cardiovascular Events in Cancer Patients on Immune Checkpoint Inhibitors

European Journal of Cancer(2024)10.1016/j.ejca.2024.115170

N/A

0DataRank · unranked

24 citations

Junmin Song, Kuan‐Yu Chi, Yu-Cheng Chang, Nutchapon Xanthavanij, Yu‐Tzu Chang +7 more